Regeneron Pharmaceuticals Total Long-Term Assets 2010-2024 | REGN
Regeneron Pharmaceuticals total long-term assets for the quarter ending September 30, 2024 were $18.108B, a 33.85% increase year-over-year.
- Regeneron Pharmaceuticals total long-term assets for 2023 were $13.601B, a 2.03% increase from 2022.
- Regeneron Pharmaceuticals total long-term assets for 2022 were $13.33B, a 16.73% increase from 2021.
- Regeneron Pharmaceuticals total long-term assets for 2021 were $11.42B, a 54.65% increase from 2020.